没有看懂，它应该把入组方案写的比较清楚，什么样的入组，分成什么样的组，

I didn't understand it. It should write the enrollment plan more clearly, what kind of enrollment, what kind of group is divided into, how is the control and the trial divided, what does this mean? All patients received background MMF. Did it take 12 weeks? I think this means that once diagnosed with 12 weeks of treatment, this treatment is all hormones plus MMF. By 12 weeks, the patient is reduced to the minimum daily dose of 2.5 mg. do you mean this? After another 52 weeks of observation, they were divided into two groups.

Did not understand, it should be written into the group program more clearly, what kind of group, divided into what kind of groups, control and test how to divide, what does this mean? Did all patients receive background MMF for 12 weeks? I think that means that once 12 weeks of treatment is diagnosed, the treatment is hormone-plus MMF, and by 12 weeks the patient has been reduced to a minimum daily dose of 2.5 milligrams. Is that what it means? Then for 52 weeks, the observations were divided into two groups.

I don't understand it. It should clearly write the enrollment scheme, what kind of enrollment, what kind of group, how to divide the control and experiment, what is the meaning of this? All patients received background MMF, did they receive 12 weeks? I think this means that once the diagnosis has been made for 12 weeks, the treatment is hormone plus MMF, and by 12 weeks, the patient has been reduced to the minimum dose of 2.5 mg per day. Do you mean this? Then 52 weeks of observation, divided into two groups.<br>